In CAD, treat-to-target statins were noninferior to high-intensity statins for a composite clinical outcome. Colivicchi F. Ann Intern Med 2023;176:JC74.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Colivicchi F. In CAD, treat-to-target statins were noninferior to high-intensity statins for a composite clinical outcome. Ann Intern Med 2023;176:JC74.
PMID: 37399550